Aptamer Group Past Earnings Performance
Past criteria checks 0/6
Aptamer Group's earnings have been declining at an average annual rate of -44.4%, while the Biotechs industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 13.3% per year.
Key information
-44.4%
Earnings growth rate
-31.1%
EPS growth rate
Biotechs Industry Growth | 11.5% |
Revenue growth rate | 13.3% |
Return on equity | -352.3% |
Net Margin | -677.4% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Aptamer Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 1 | -7 | 4 | 0 |
30 Sep 23 | 1 | -7 | 4 | 0 |
30 Jun 23 | 2 | -8 | 5 | 0 |
31 Mar 23 | 3 | -6 | 6 | 0 |
31 Dec 22 | 4 | -4 | 6 | 0 |
30 Sep 22 | 4 | -3 | 6 | 0 |
30 Jun 22 | 4 | -2 | 5 | 0 |
31 Dec 21 | 2 | -2 | 3 | 0 |
30 Sep 21 | 2 | -2 | 3 | 0 |
30 Jun 21 | 1 | -2 | 3 | 0 |
31 Mar 20 | 1 | -1 | 1 | 0 |
31 Mar 19 | 1 | 0 | 1 | 0 |
Quality Earnings: APTA is currently unprofitable.
Growing Profit Margin: APTA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: APTA is unprofitable, and losses have increased over the past 5 years at a rate of 44.4% per year.
Accelerating Growth: Unable to compare APTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: APTA is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-14.4%).
Return on Equity
High ROE: APTA has a negative Return on Equity (-352.31%), as it is currently unprofitable.